, Aug. 9, 2012 /PRNewswire/ -- Olin Corporation (NYSE: OLN)
announced today the pricing of its offering of
aggregate principal amount of Senior Notes due 2022 (the "Senior Notes"). The Senior Notes will mature on
August 15, 2022
, will have an interest rate of 5.50% and will be issued at 100% of par value. Interest will be paid semi-annually on the 15th day of February and August, beginning
February 15, 2013
. The Senior Notes will be sold pursuant to Olin's shelf registration statement on file with the Securities and Exchange Commission. The underwriters for the transaction are BofA Merrill Lynch, Citigroup Global Markets Inc. and Wells Fargo Securities, LLC. Proceeds from the Senior Notes are expected to be used to pay a portion of the purchase price for the acquisition of K. A. Steel Chemicals Inc. If the K. A. Steel Chemicals Inc. acquisition has not been consummated on or before the closing of the Senior Notes offering, the proceeds of the offering will be placed in an account pending the completion of the K. A. Steel Chemicals Inc. acquisition.
Olin has filed a registration statement on Form S-3 (including a prospectus) with the Securities and Exchange Commission for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and the prospectus supplement thereto and the other documents that Olin has filed with the SEC for more complete information about Olin and this offering. These documents are available at no charge by visiting EDGAR on the SEC website at
. Alternatively, these documents will be made available upon request to any underwriter participating in the offering. Interested parties may obtain a prospectus and the related prospectus supplement from BofA Merrill Lynch, 222 Broadway, 7th Floor,
New York, NY
10038, Attention: Prospectus Department, or by calling: 1-800-294-1322 or emailing:
This press release does not constitute an offer to sell or a solicitation of an offer to buy the Senior Notes, which may be made only pursuant to the terms of the relevant prospectus supplement (including the prospectus).